BME:SAN
BME:SANBanks

Does Santander’s 2025 Valuation Still Make Sense After a 111.6% Year To Date Surge?

If you are wondering whether Banco Santander is still good value after such a massive run, you are not alone. This is exactly the right moment to dig into what the market is really pricing in. The stock has climbed 1.1% over the last week, 5.3% over the past month, and an eye catching 111.6% year to date, building on a 113.3% 1 year gain and an even more dramatic 265.0% and 295.2% over 3 and 5 years respectively. These moves have come as investors refocus on European banks amid a shifting...
BME:ITX
BME:ITXSpecialty Retail

Reassessing Inditex Valuation After Strong Multi Year Rally and Mixed Model Signals

If you are wondering whether Industria de Diseño Textil is still attractive after its substantial rise in recent years, or if the easy money has already been made, you are not alone. The stock has ticked up 3.2% over the last week and 2.4% over the past month, but it is still down 2.5% year to date and about 8.0% over the last year, trading near €49.07 after more than doubling over 3 and 5 years. Recent market chatter has focused on how Inditex is consolidating its global fashion footprint,...
BME:CBAV
BME:CBAVHealthcare

Undiscovered Gems in Europe for December 2025

As the European market continues to show resilience with the STOXX Europe 600 Index rising by 2.35%, investors are keeping a close eye on economic indicators, such as subdued inflation rates that suggest stability around the ECB's target. In this environment, identifying promising small-cap stocks becomes crucial, as these companies often offer unique growth opportunities that align well with current market dynamics and economic conditions.
BME:OHLA
BME:OHLAConstruction

OHLA (BME:OHLA) Q3 Net Loss of €17.2M Persists Despite Margin Gains, Testing Turnaround Narrative

Obrascón Huarte Lain (BME:OHLA) just released its Q3 2025 numbers with revenue of €959.8 million and net income from continuing operations of -€17.2 million. Over recent periods, the company has seen revenue move from €783.1 million in Q1 to €959.8 million in Q3, while net income slipped from -€16.7 million to -€17.2 million. Margins remain under pressure as OHLA works to return to profitability. See our full analysis for Obrascón Huarte Lain. Now that the headline numbers are out, the next...
BME:SAN
BME:SANBanks

Banco Santander (BME:SAN): Assessing Valuation After Notable Weekly Share Price Gains

Banco Santander (BME:SAN) has attracted fresh attention as its stock climbed 1% in the last day and nearly 4% over the past week. Investors seem keen to revisit Santander’s valuation in light of these recent gains. See our latest analysis for Banco Santander. Santander’s momentum has hardly gone unnoticed. The stock’s climb this week comes on the heels of an impressive year-to-date share price return of nearly 110%, with its total shareholder return topping 116% over the past year. Short-term...
BME:CIRSA
BME:CIRSAHospitality

Cirsa (BME:CIRSA) Margins Fall to 1.8%, Undercutting Bullish Growth Expectations

Cirsa Enterprises (BME:CIRSA) just posted its Q3 2025 results, revealing revenue of €560.6 million and basic EPS of €0.22. Net income stood at €15.6 million. Looking back, quarterly revenues have moved from €531.5 million in Q3 2024 to €578.7 million last quarter, as reported EPS shifted from a loss of €0.05 in Q4 2024 to €0.26 in Q1 2025. Margins continue to be in the spotlight as investors weigh the company’s profit trajectory against headline growth. See our full analysis for Cirsa...